Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Murae Organisor Ltd (542724)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542724 NSE: Trading | Small Cap | Murae Organisor Share Price
₹0.19 0.00 (0.00%)
As on 25-Mar'26 16:59
Murae Organisor Ltd (542724)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542724 NSE: Trading | Small Cap | Murae Organisor Share Price
₹0.19 0.00 (0.00%)
As on 25-Mar'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹39 Cr.
Current Price
₹0.2
52-Week Low / High
₹0 / 1
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
40.3
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
26613.13%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹204.5 Cr.
Face Value
₹1
All Time Low / High
₹0.19 / 9.91
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Murae Organisor Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 17.1% | 22% | 24.9% | 24% | 17.4% | 4.2% | 12.3% | 11.7% | 0.8% | 4.2% | - |
| Value Creation Index ⓘ | 0.2 | 0.6 | 0.8 | 0.7 | 0.2 | -0.7 | -0.1 | -0.2 | -0.9 | -0.7 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 18.6 | 23.3 | 35.4 | 50.7 | 55.1 | 41.1 | 21 | 15 | 3.2 | 855 | 859 |
| Sales YoY Gr. | - | 25.7% | 51.8% | 43.1% | 8.7% | -25.5% | -48.8% | -28.9% | -78.6% | 26,613.1% | - |
| Adj EPS ⓘ | 0 | 0 | 0.1 | 0.2 | 0.1 | 0 | 0.1 | 0.1 | 0 | 0 | 0.1 |
| YoY Gr. | - | 33.3% | 100% | 87.5% | -26.7% | -90.9% | 1300% | -14.3% | -100% | NA | - |
| BVPS (₹) ⓘ | 0.3 | 0.4 | 0.4 | 0.5 | 0.9 | 0.9 | 1 | 1.1 | 1 | 1 | 1.2 |
| Adj Net Profit ⓘ | 0.1 | 0.1 | 0.9 | 1.7 | 1.8 | 0.1 | 2.2 | 2 | 0.1 | 7.5 | 14 |
| Cash Flow from Ops. ⓘ | -0.3 | 0.1 | -7.1 | -0.5 | -3.5 | -7.1 | 2.6 | 0.3 | -15.9 | -323 | - |
| Debt/CF from Ops. ⓘ | -7.2 | 24.1 | -1 | -20 | -2.7 | -1.6 | 3.4 | 33.3 | -0 | -0.7 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 53% | 73% | 243.8% | 26613.1% | ||||
| Adj EPS ⓘ | 3.3% | -18.3% | -34.1% | NA | ||||
| BVPSⓘ | 13% | 3% | 0% | 2% | ||||
| Share Price | - | -53.8% | -25% | -70.3% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 7.4 | 9.9 | 28 | 30.8 | 17.9 | 0.6 | 14.3 | 11.2 | 0.1 | 5.7 | 6.5 |
| Op. Profit Mgn % ⓘ | 2.8 | 1.7 | 4.4 | 6.5 | 2.3 | -18.9 | -21 | 11.9 | -14.5 | 1.2 | 1.2 |
| Net Profit Mgn % ⓘ | 0.6 | 0.6 | 2.5 | 3.3 | 3.3 | 0.2 | 10.6 | 13.3 | 1.7 | 0.9 | 1.7 |
| Debt to Equity ⓘ | 1.4 | 1.4 | 1.7 | 1.6 | 0.6 | 0.8 | 0.5 | 0.5 | 0 | 1 | 1 |
| Working Cap Days ⓘ | 0 | 149 | 155 | 151 | 182 | 264 | 479 | 687 | 7,764 | 152 | 241 |
| Cash Conv. Cycle ⓘ | 0 | 71 | 89 | 96 | 112 | 205 | 443 | 592 | 2,599 | 16 | 222 |
Valuation of Murae Organisor - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Murae Organisor Ltd FAQs
The current trading price of Murae Organisor on 25-Mar-2026 16:59 is ₹0.19.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Mar-2026 the market cap of Murae Organisor stood at ₹38.85 Cr
The latest P/E ratio of Murae Organisor as of 24-Mar-2026 is 2.56.
The latest P/B ratio of Murae Organisor as of 24-Mar-2026 is 0.17.
The 52-week high of Murae Organisor is ₹0.73 and the 52-week low is ₹0.19.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Murae Organisor is ₹859 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Murae Organisor Ltd is a average quality company.
The key valuation ratios of Murae Organisor Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
No data found
About Murae Organisor Ltd
Earum Pharmaceuticals
Earum Pharmaceuticals was originally incorporated as 'Earum Pharmaceuticals Private Limited' on July 26, 2012 vide Registration no. 071299 under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Further, pursuant to Special Resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 10, 2019, the company was converted into a Public Limited Company and consequently the name of the Company was changed from 'Earum Pharmaceuticals Private Limited' to 'Earum Pharmaceuticals Limited' vide a fresh Certificate of Incorporation dated January 23, 2019 issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company post conversion.
Business area of the company
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.
Milestones:
2012: Incorporation of the Company in the name of 'Earum Pharmaceuticals Private Limited'.
2014-15: Total turnover of the Company reached to Rs. 8 crores.
2015-16: Crossed Turnover of Rs. 18 crores.
2016-17: Crossed Turnover of Rs. 23 crores.
2017-18: Crossed Turnover of Rs. 35 crores.
2019: Conversion of the Company from Private Limited to Public Limited Company.
You have 34 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
